U.S. stocks opened higher on Tuesday, rebounding sharply from Monday's losses, as investors hoped Greece would strike a last-minute deal to avoid an exit from the euro zone.
JPMorgan analyst Cory Kasimov reiterated an Overweight rating and boosted his price target on Juno Therapeutics (NASDAQ: JUNO) to $83.00 (from $66.00) following the company's 10-year collaboration with Celgene (NASDAQ: CELG).
Apollo Education Group Inc., owner of the University of Phoenix, slid as much as 16 percent after it lowered profit and revenue forecasts and said enrollment will fall by 50,000 next year.
The signs of a struggling economy can be seen in the shuttered restaurants and bars in previously thriving Old San Juan. In the faces of business owners who spend much of their day trying to coax customers through the doors.
Home price increases moderated a bit in April despite limited housing supplies, solid job growth and strong consumer confidence. The Standard & Poor's/Case Shiller index of 20 large cities rose 4.9% compared with a year earlier, down slightly from a 5% ...